Inotiv Inc Stock Performance
| NOTV Stock | USD 0.50 0.01 1.96% |
The company retains a Market Volatility (i.e., Beta) of 2.56, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inotiv will likely underperform. At this point, Inotiv Inc has a negative expected return of -1.19%. Please make sure to check out Inotiv's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Inotiv Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Inotiv Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2026. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
1 | Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025 | 11/21/2025 |
2 | Why Inotiv Inc. stock could rally in 2025 - 2025 Performance Recap Consistent Growth Equity Picks - B NI V | 11/26/2025 |
3 | Disposition of 2000 shares by Neff R Matthew of Inotiv at 0.8853 subject to Rule 16b-3 | 12/01/2025 |
4 | Insights Ahead Inotivs Quarterly Earnings | 12/02/2025 |
5 | Inotiv Inc Q4 2025 Earnings Call Highlights Revenue Growth Amid Cybersecurity Challenges | 12/04/2025 |
6 | Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities | 12/11/2025 |
7 | Is Inotiv Inc. stock a safe investment in uncertain markets - Bond Market Stepwise Swing Trade Plans - ulpravda.ru | 01/08/2026 |
8 | Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery | 01/13/2026 |
9 | Acquisition by Andrea Castetter of 10000 shares of Inotiv at 0.5956 subject to Rule 16b-3 | 01/15/2026 |
| Begin Period Cash Flow | 21.4 M | |
| Total Cashflows From Investing Activities | -12.9 M |
Inotiv Relative Risk vs. Return Landscape
If you would invest 124.00 in Inotiv Inc on November 3, 2025 and sell it today you would lose (74.00) from holding Inotiv Inc or give up 59.68% of portfolio value over 90 days. Inotiv Inc is currently does not generate positive expected returns and assumes 7.0498% risk (volatility on return distribution) over the 90 days horizon. In different words, 63% of stocks are less volatile than Inotiv, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Inotiv Target Price Odds to finish over Current Price
The tendency of Inotiv Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.50 | 90 days | 0.50 | about 88.49 |
Based on a normal probability distribution, the odds of Inotiv to move above the current price in 90 days from now is about 88.49 (This Inotiv Inc probability density function shows the probability of Inotiv Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.56 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Inotiv will likely underperform. Additionally Inotiv Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Inotiv Price Density |
| Price |
Predictive Modules for Inotiv
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Inotiv Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Inotiv's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Inotiv Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Inotiv is not an exception. The market had few large corrections towards the Inotiv's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Inotiv Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Inotiv within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.38 | |
β | Beta against Dow Jones | 2.56 | |
σ | Overall volatility | 0.25 | |
Ir | Information ratio | -0.19 |
Inotiv Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Inotiv for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Inotiv Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Inotiv Inc generated a negative expected return over the last 90 days | |
| Inotiv Inc has high historical volatility and very poor performance | |
| Inotiv Inc has some characteristics of a very speculative penny stock | |
| Inotiv Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 513.02 M. Net Loss for the year was (68.62 M) with profit before overhead, payroll, taxes, and interest of 120.98 M. | |
| Inotiv Inc currently holds about 21.24 M in cash with (10.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Inotiv Inc has a frail financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery |
Inotiv Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Inotiv Stock often depends not only on the future outlook of the current and potential Inotiv's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Inotiv's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.5 M | |
| Cash And Short Term Investments | 21.7 M |
Inotiv Fundamentals Growth
Inotiv Stock prices reflect investors' perceptions of the future prospects and financial health of Inotiv, and Inotiv fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Inotiv Stock performance.
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.0298 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 455.08 M | ||||
| Shares Outstanding | 34.4 M | ||||
| Price To Earning | 30.91 X | ||||
| Price To Book | 0.13 X | ||||
| Price To Sales | 0.03 X | ||||
| Revenue | 513.02 M | ||||
| Gross Profit | 120.98 M | ||||
| EBITDA | 24.75 M | ||||
| Net Income | (68.62 M) | ||||
| Cash And Equivalents | 21.24 M | ||||
| Cash Per Share | 0.83 X | ||||
| Total Debt | 409.02 M | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 1.60 X | ||||
| Book Value Per Share | 3.96 X | ||||
| Cash Flow From Operations | (10.46 M) | ||||
| Earnings Per Share | (2.11) X | ||||
| Market Capitalization | 17.71 M | ||||
| Total Asset | 771.11 M | ||||
| Retained Earnings | (630.81 M) | ||||
| Working Capital | (362.19 M) | ||||
About Inotiv Performance
Evaluating Inotiv's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Inotiv has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Inotiv has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 42.86 | 43.11 | |
| Return On Tangible Assets | (0.18) | (0.17) | |
| Return On Capital Employed | (0.17) | (0.16) | |
| Return On Assets | (0.10) | (0.10) | |
| Return On Equity | (0.58) | (0.55) |
Things to note about Inotiv Inc performance evaluation
Checking the ongoing alerts about Inotiv for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Inotiv Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Inotiv Inc generated a negative expected return over the last 90 days | |
| Inotiv Inc has high historical volatility and very poor performance | |
| Inotiv Inc has some characteristics of a very speculative penny stock | |
| Inotiv Inc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 513.02 M. Net Loss for the year was (68.62 M) with profit before overhead, payroll, taxes, and interest of 120.98 M. | |
| Inotiv Inc currently holds about 21.24 M in cash with (10.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Inotiv Inc has a frail financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery |
- Analyzing Inotiv's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Inotiv's stock is overvalued or undervalued compared to its peers.
- Examining Inotiv's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Inotiv's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Inotiv's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Inotiv's stock. These opinions can provide insight into Inotiv's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Inotiv Stock Analysis
When running Inotiv's price analysis, check to measure Inotiv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inotiv is operating at the current time. Most of Inotiv's value examination focuses on studying past and present price action to predict the probability of Inotiv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inotiv's price. Additionally, you may evaluate how the addition of Inotiv to your portfolios can decrease your overall portfolio volatility.